« A disruptive technology, which can be applied in the treatment of numerous conditions »

> Press releases 2021

2020 full-year results and update on the progress of main programs

Download PDF File (1443Ko)

THERANEXUS extends the capabilities of Neurolead, its active agent screening platform, to autophagy and neurological lysosomal storage disorders

Download PDF File (326Ko)

Semi-annual liquidity contract summary - H2 2020

Download PDF File (538Ko)

THERANEXUS presents an update on the progress of its main programs and announces its cash position as of 31 December 2020

Download PDF File (538Ko)